HEORStrategies’ scientist Dr. Naomi Sacks, along with clinicians and industry leaders, is presenting results of a study of antibiotic treatment patterns and treatment failure (TF) in uncomplicated UTI (uUTI) in the US at the 2024 European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), held in Barcelona April 27-30. In this study, Sacks and colleagues analyzed US healthcare claims data and found that uUTI patients with treatment failure had higher rates of UTI recurrence, and that patient demographics, including older age and clinical risk factors, may be associated with the risk of TF and recurrent UTI.